Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI study

Winton-Brown, Toby T, Allen, Paul, Bhattacharrya, Sagnik, Borgwardt, Stefan J, Fusar-Poli, Paolo, Crippa, Jose A, Seal, Marc L, Martin-Santos, Rocio +4 more·2011·Neuropsychopharmacology
DOI 10.1038/npp.2011.17

Cited by (146)

Items 101–146 of 146

  1. Neuroimaging as a Translational Tool in Animal and Human Models of Schizophrenia
    Thomas Steckler, Giacomo Salvadore · 2012 · Elsevier eBooks
  2. Neuroimaging studies of cannabidiol and potential neurobiological mechanisms relevant for alcohol use disorders: a systematic review
    Tristan P. Hurzeler, Joshua Watt, Warren Logge, Ellen E Towers, Anastasia S. Suraev, Nicholas Lintzeris, Paul Haber, Kirsten C. Morley · 2024 · Journal of Cannabis Research
  3. Chronic Δ9-tetrahydrocannabinol exposure in adolescent nonhuman primates: persistent abnormalities in economic demand and brain functional connectivity
    Brian D. Kangas, Harshawardhan U. Deshpande, Sarah Louise Withey, Roger D. Spealman, Jack Bergman, Stephen John Kohut · 2024 · Neuropsychopharmacology
  4. Serum Proteomic Analysis of Cannabis Use Disorder in Male Patients
    Fawaz F. Alasmari, Sary Alsanea, Assim Abdulaziz Alfadda, Ibrahim O. Alanazi, Mohthash Musambil, Afshan Masood, Faleh Alqahtani, Omer I. Fantoukh, Abdullah F. Alasmari, Hicham Benabdelkamel · 2021 · Molecules
  5. A Systematic Review of Cannabis and Anxiety: Chicken or Egg?
    Lily G. Blyth, Cassandra Seal, Maryam Sorkhou, Darby J. E. Lowe, Tony Peter George · 2025 · Current Addiction Reports
  6. Acute effects of Δ9-tetrahydrocannabinol and cannabidiol on auditory mismatch negativity
    Lisa‐Marie Greenwood, Samantha J. Broyd, Hendrika H. van Hell, Juanita Todd, Alison Linda Jones, Robin M. Murray, Rodney J. Croft, Patricia Therese Michie, Nadia Solowij · 2021 · Psychopharmacology
  7. Impact of cannabis use on brain metabolism using 31P and 1H magnetic resonance spectroscopy
    M. Fenzl, Martin Backens, Silviu‐Vasile Bodea, Miriam Wittemann, Florian Werler, Jule Brielmaier, Robert Christian Wolf, Wolfgang Reith · 2023 · Neuroradiology
  8. Cannabidiol and cognition: a literature review of human randomized controlled trials
    Jyotpal Singh, Chase J. Ellingson, M. Abdullah Shafiq, Jane Alcorn, J. Patrick Neary · 2025 · Behavioural Pharmacology
  9. Daily Cannabidiol Administration for 10 Weeks Modulates Hippocampal and Amygdalar Resting-State Functional Connectivity in Cannabis Users: A Functional Magnetic Resonance Imaging Open-Label Clinical Trial
    Valentina Lorenzetti, Eugene McTavish, Samantha J. Broyd, Hendrika van Hell, Diny Thomson, Eleni P. Ganella, Akhil Kottaram, Camilla Beale, Jennifer H. Martin, Peter Galettis et al. · 2023 · Cannabis and Cannabinoid Research
  10. Daily cannabidiol and L-theanine beverage consumption does not alter anxiety, fatigue, cognitive function, or natural killer cell function: A randomized, controlled trial in healthy, young adults
    Arjun H. Ramani, Ryland Townsend, Edwin Rodriguez, James M. Haughian, Laura K. Stewart · 2024 · Brain Behavior and Immunity Integrative
  11. Le cannabis et ses effets délétères : pour un débat plus nuancé
    Laurence Jobidon, Didier Jutras‐Aswad · 2018 · Drogues santé et société
  12. The Development of Cannabidiol as a Psychiatric Therapeutic: A Review of Its Antipsychotic Efficacy and Possible Underlying Pharmacodynamic Mechanisms
    Shahin Jalali · 2013 · International Neuropsychiatric Disease Journal
  13. Psychotomimetic and Cognitive Effects of Δ 9 -Tetrahydrocannabinol in Laboratory Settings
    John Daniel Cahill, Swapnil Gupta, Jose Cortes-Briones, Rajiv Radhakrishnan, Mohamed A. Sherif, Deepak Cyril D’Souza · 2017 · Elsevier eBooks
  14. Low Abuse Potential of Plant-Derived Highly Purified Cannabidiol: A Narrative Review
    Hitoshi Yamamoto, Satish Dayal, Charlotte Nortvedt, Ichiro Takumi · 2025 · YAKUGAKU ZASSHI
  15. Cannabidiol and Cannabis Use Disorder
    María S. García‐Gutiérrez, Francisco Navarrete, Adrián Viudez‐Martínez, Ani Gasparyan, Esther Caparrós, Jorge Manzanares · 2018 · Springer eBooks
  16. Psicose induzida por drogas recreativas: uma revisão de literatura
    Daniel Nobrega Medeiros, Juliana Fernandes de Souza Ribeiro, Larissa Alexsandra da Silva Neto Trajano · 2021 · Research Society and Development
  17. Potential Therapeutic Strategy for Neurodegenerative Disorders: Insights from Natural Cannabis Compounds and Analogues
    Lei Tian, Bingxing Zhang, Xiuding Yang, Xiaopei Zhai, Yue Gao, Yunfei Zhang, Xiaolin Xie, Dezhu Zhang, Chengyuan Liang · 2025 · Springer eBooks
  18. The subjective effects of △9-tetrahydrocannabinol: A systematic review and dose-response meta-regression
    Isabella Goodwin, Dominic Oliver, Edward Chesney, Alexandra Gaillard, Simiao Wang, Andrea Wong koo, Kat Petrilli, Martine Skumlien, Amir Hossein Dakhili, Stina Wigroth et al. · 2026 · Neuroscience & Biobehavioral Reviews
  19. Cannabidiol: de nieuwe haarlemmerolie of een hype?
    Raymond J.M. Niesink, Margriet van Laar · 2012 · Verslaving
  20. Cannabis and Hallucinations: Studies in Human Subjects
    Paul Allen, Toby Winton‐Brown · 2012 · Springer eBooks
  21. Neuroimaging and Genetics of the Acute and Chronic Effects of Cannabis
    Rocío Martín‐Santos, José Alexandre S. Crippa, Sagnik Bhattacharyya · 2017 · Elsevier eBooks
  22. Polydrug users, use of cannabinoids and abuse potential: A focus on cannabidiol (CBD)
    Kerri A. Schoedel, Naama Levy‐Cooperman · 2023 · Elsevier eBooks
  23. Investigating the Role of the Endocannabinoid System in Early Psychosis
    Aisling O’Neill, Sagnik Bhattacharyya · 2017 · Journal of Exploratory Research in Pharmacology
  24. Cannabidiol as a Potential Novel Therapeutic Agent for Psychotic Disorders
    Serena Deiana, Erica Zamberletti · 2017 · Elsevier eBooks
  25. Troubles psychiatriques chez le consommateur de cannabis : l'aide au diagnostic par l'analyse capillaire ?
    Э. А. Паин · 2013 · HAL
  26. Receptor-enriched analysis of functional connectivity (REACT) for understanding cannabinoid neuropsychopharmacology
    Ekaterina Shatalina, Natalie Ertl, Kat Petrilli, Shelan Ofori, Anna Borissova, Claire Mokrysz, H. Valerie Curran, Will Lawn, Tom P. Freeman, Oliver David Howes et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  27. Tratamento repetido com canabidiol atenua alterações comportamentais e moleculares em um modelo de esquizofrenia baseado no antagonismo dos receptores NMDA
    Felipe Villela Gomes · 2016
  28. The acute cognitive, psychological and electrophysiological effects of cannabis constituents
    Amir Englund · 2015
  29. Novel approaches in clinical development of cannabinoid drugs
    Linda E. Klumpers · 2014 · Leiden Repository (Leiden University)
  30. The Efficacy of Cannabidiol in Mitigating Delta-9-Tetrahydrocannabinol-induced Harms: A Systematic Review
    de Freitas, Lauren Alyson · 2020
  31. Neuroprotective Effects of Cannabidiol Following Concussion: A Case Study
    Jyotpal Singh · 2019 · oURspace (University of Regina)
  32. An insight into the acute effects of cannabidiol on human brain function and their relationship with the brain expression of its molecular targets: a neuroimaging meta-regression analysis
    Brandon Gunasekera, Cathy Davies, Grace Blest‐Hopley, Robin Paul Wilson, Geraldo F. Busatto, José Alexandre S. Crippa, Fábio Duran, Antônio Waldo Zuardi, Mattia Veronese, Joaquim Raduà et al. · 2022 · Research Square
  33. Neurological Effects of Cannabis
    Ivan A. Ross · 2023 · Springer eBooks
  34. Psychotropic Effects of Cannabis
    Ivan A. Ross · 2023 · Springer eBooks
  35. Δ9-Tetrahydrocannabinol Alters Limbic and Frontal Functional Brain Connectomes Among Young Adult Cannabis Users
    Zachary G. Anderson, Matthew Gunn, Emily Jones, Olusola Ajilore, K. Luan Phan, Harriet de Wit, Heide Klumpp, Vince D. Calhoun, Natania A. Crane · 2025 · Biological Psychiatry Cognitive Neuroscience and Neuroimaging
  36. Acute and chronic effects of cannabinoids on human brain: gene-environment interactions related to psychiatric disorders
    Albert Batalla · 2014 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
  37. Additional file 6 of Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications
    Ainhoa Bilbao, Spanagel, Rainer · 2022 · Figshare
  38. Additional file 3 of Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications
    Ainhoa Bilbao, Spanagel, Rainer · 2022 · Figshare
  39. Additional file 1 of Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications
    Ainhoa Bilbao, Spanagel, Rainer · 2022 · Figshare
  40. Additional file 4 of Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications
    Ainhoa Bilbao, Spanagel, Rainer · 2022 · Figshare
  41. Additional file 5 of Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications
    Ainhoa Bilbao, Spanagel, Rainer · 2022 · Figshare
  42. Additional file 2 of Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications
    Ainhoa Bilbao, Spanagel, Rainer · 2022 · Figshare
  43. Music and Psychoactive Substances: Cultural Practices, Adolescent Development and Music Therapy in Addiction Treatment
    Jörg Christfried Fachner, Filippo Pasqualitto, Clemens Maidhof · 2026 · IntechOpen eBooks
  44. Self-reported Visual Function After Non-medical Cannabis Use: A Cross-sectional Survey
    Abd Elaziz Mohamed Elmadina, Salma Ibrahim Elemin Hagar · 2026 · Sudan Journal of Medical Sciences
  45. Functional neuroimaging of Cannabidiol in stress and anxiety: a systematic review
    Omar Rutledge, Richard Goyette, Kimberly L. Wang, Madelynn S. Park, John D. E. Gabrieli · 2026 · Frontiers in Neuroimaging
  46. Effects of Cannabidiol on Auditory Mismatch Negativity in Autistic Children
    Karan Budhiraja, Nina-Francesca Parrella, Aron T. Hill, Luke A. Downey, Sarah J. Catchlove, Peter G. Enticott, Talitha C. Ford · 2026 · medRxiv